Farxiga Now FDA-Approved to Treat CKD
https://unsplash.com/photos/_jbClosDsD4

Farxiga Now FDA-Approved to Treat CKD

According to BioSpace, Farxiga (dapagliflozin), a treatment for patients with chronic kidney disease (CKD) and a risk of progression, recently became FDA-approved. Developed by AstraZeneca, the therapy is specifically designed…

Continue Reading Farxiga Now FDA-Approved to Treat CKD
Bladder Dysfunction Common in Pediatric Patients with PWS
Unsplash: https://unsplash.com/photos/g51F6-WYzyU

Bladder Dysfunction Common in Pediatric Patients with PWS

There are many reasons why medical research is important. It helps to amplify the patient voice, improve disease-related knowledge, and determine potential treatment goals. Additionally, medical research provides insight into…

Continue Reading Bladder Dysfunction Common in Pediatric Patients with PWS